Scholar IQ
Help
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Lung Cancer Research Studies

TopicLeading institutions, researchers & key papers

This cluster of papers represents a comprehensive exploration of small cell lung cancer, covering topics such as genomic profiles, immunotherapy, chemotherapy, prognostic factors, biomarkers, targeted therapy, clinical trials, metastasis, and tumor markers.

36,703
Works
406,950
Citations
How has Lung Cancer Research Studies's publication output changed over time?
ScholarIQpublication output · 2018
1
2018
Who are the most-cited researchers behind Lung Cancer Research Studies?
ScholarIQtop researchers by citations
1
Georgina V. Long · Cancer Immunotherapy and Biomarkers
1,822 works178,195 citations
2
Jeffrey A. Sosman · Melanoma and MAPK Pathways
938 works129,555 citations
3
Julie R. Brahmer · Cancer Immunotherapy and Biomarkers
854 works125,298 citations
4
Timothy A. Chan · Cancer Immunotherapy and Biomarkers
1,079 works111,482 citations
5
Luis Paz‐Ares · Lung Cancer Treatments and Mutations
1,378 works96,283 citations
What are the most-cited papers on Lung Cancer Research Studies?
ScholarIQmost cited works
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J. Hochmair, Florian Huemer, György Losonczy, Melissa L. Johnson, Makoto Nishio, Martin Reck, Tony Mok, Sivuonthanh Lam, David S. Shames, Juan Liu, Beiying Ding, Ariel López-Chávez, Fairooz F. Kabbinavar, Wei Lin, Alan Sandler, Stephen V. Liu
New England Journal of Medicine. 20183,542 CitationsOPEN ACCESS
Where is Lung Cancer Research Studies research published, and who funds it?
ScholarIQvenues & funding sources
TOP FUNDERS
National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock
How much of the research on Lung Cancer Research Studies is open access?
ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
100%
Closed
0%
Who collaborates most closely around Lung Cancer Research Studies?
ScholarIQco-authorship network
PL
100%
MOST FREQUENT PARTNER INSTITUTIONS
Related on ScholarIQ
Centrum Onkologii
Institution
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Paper
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Paper
Nasopharyngeal carcinoma
Paper
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
Paper
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Paper
470M+ articles · free account